Skip to content

Merchavia

  • HOME
  • COMPANY PROFILE
  • LIFE SCIENCE INVESMENTS
  • MEDICAL DISTRIBUTION
  • INVESTOR RELATIONS
  • MEDIA
  • CONTACT
  • HOME
  • COMPANY PROFILE
  • LIFE SCIENCE INVESMENTS
  • MEDICAL DISTRIBUTION
  • INVESTOR RELATIONS
  • MEDIA
  • CONTACT
Read more about the article Cardiacsense completed 500K$ investment round on a 20M$ company valuation
pdf1

Cardiacsense completed 500K$ investment round on a 20M$ company valuation

  • Post published:27/05/2018
Read more about the article Positive Results in a Multi-Center Clinical Trial of CDx
pdf1

Positive Results in a Multi-Center Clinical Trial of CDx

  • Post published:21/05/2018
Read more about the article Juventas’s trial’s end-points for closing wounds on a diabetic foot not met
pdf1

Juventas’s trial’s end-points for closing wounds on a diabetic foot not met

  • Post published:18/01/2018
Read more about the article CEO’s letter to shareholders – annual summary
pdf1

CEO’s letter to shareholders – annual summary

  • Post published:08/01/2018
← Newer Posts

Investor Relations

  • Investors Lobby
  • Company Profile
  • Company Presentation
  • Immediate Reports
  • Financial Reports
  • Investors News
  • News in the Media
  • Management
  • Stock Chart
  • FAQ
  • Mail Alert
  • Contact

© all rights preserve to Merchavia LTD

HOME
COMPANY PROFILE
LIFE SCIENCE INVESMENTS
INVESTOR RELATIONS
Accessibility
CONTACT